MultiOmic Health announces discovery of novel endotypes and biomarkers for diabetic kidney disease

MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney disease (DKD) patients. This breakthrough enables precise segmentation of DKD patients by disease trajectory over time, marking a pivotal advancement in precision medicine for DKD. MultiOmic’s CEO Robert Thong will present these findings at the LSX Investival Conference in London on 18th November 2024.

Rousselot and IamFluidics Launch Revolutionary Dissolvable Microcarrier for Scalable Cell Culturing

Rousselot, Darling Ingredients’ premier collagen and gelatin brand, and IamFluidics, a leader in microparticle innovation, today announced the launch of a novel research grade dissolvable microcarrier for adherent cell culturing. The product is designed to streamline and scale-up processes for advanced cell therapies, biologics manufacturing and cultured meat production.

William H Morris, MD MBA, Joins Ambience Healthcare as Chief Medical Officer

AppOmni and Cisco Partner to Extend SaaS Security with End-to-End Zero Trust From Endpoint to the Application

AppOmni, the leader in SaaS security today announced a significant partnership that combines the company’s Zero Trust Posture Management (ZTPM) solution with Cisco’s Security Service Edge (SSE) technology suite to enable zero trust principles at the application layer in Security-as-a-Service (SaaS) applications.

The MAP Group acquires SKC as it continues to expand internationally

UK-based pharma strategic consultancy, The MAP Group has acquired market access and pricing consultancy, SKC Beratungsgesellschaft mbH as it continues to expand internationally.

Oxford Nanopore Announces Landmark UK Government Partnership to Advance Genomics-Driven Healthcare Innovation in the UK

Oxford Nanopore announced a landmark strategic partnership that brings together Genomics England, UK Biobank, and NHS England to enable genomics-based translational research and accelerate the development and adoption of Oxford Nanopore’s ground-breaking genomics technology in the NHS.

Nuclera’s eProtein Discovery system installed at Domainex to streamline protein production services

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, and Domainex, a multi-award winning provider of integrated, pre-clinical drug discovery services, today announced that Domainex is the first contract research organization (CRO) to have installed the eProtein Discovery system and offer protein production services using the technology.

Endor Labs Named to Fortune Cyber 60 for Second Consecutive Year

Endor Labs, the leader in open source software security, has once again been selected to the prestigious Fortune Cyber 60 list, the second consecutive year it has received this recognition.

VIZIA Diagnostics Selects PathAI and the AISight Image Management System to Support the Transition to Digital and AI-Powered Pathology

PathAI, a leader in digital and AI-powered pathology solutions, and VIZIA Diagnostics, a GI- specialized pathology laboratory based in Alpharetta, Georgia, have announced that VIZIA has adopted PathAI’s AISightⓇ1 Image Management System (IMS) and AI technology to advance the precision and operational efficiency of its pathology services.

SPT Labtech and ICE Bioscience Launch Joint Automated Laboratory in China for Intelligent Drug Screening

1upHealth Appoints Andrew Boyd as New Chief Executive Officer

Clearwater and Guidehouse Partner to Help Healthcare Organizations Solve Key Cybersecurity Challenges

VALANX Biotech and Fina Biosolutions Introduce ClickCRM for Rapid Conjugate Vaccine Development

VALANX Biotech (VALANX) and Fina Biosolutions LLC (FinaBio) today announced the signing of a joint IP and licensing agreement. The companies will launch ClickCRM™, a ready-to-conjugate version of CRM197, an antigenic carrier protein used for making conjugate vaccines. The new product enables the rapid, high-efficiency conjugation of carrier proteins to polysaccharide antigens for the generation of conjugate vaccines.

Phreesia Achieves Oracle Validated Integration with Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration

Phreesia announced that it has achieved Oracle Validated Integration with Oracle Health Electronic Health Record (EHR) Expertise for its integration of the Phreesia platform.

Sapio Sciences Expands Collaboration With AWS to Advance Science-Aware AI Vision

Sapio Sciences today announced it has strengthened its long-term relationship with Amazon Web Services, Inc. (AWS) through the integration of AWS Bedrock with the Sapio Platform. This integration makes advanced generative AI models readily accessible to scientists and researchers within the same secure AWS environment that already powers Sapio’s Laboratory Information Management System (LIMS) and Electronic Lab Notebook (ELN).

Quris-AI Acquires Nortis

Today, Quris-AI announced the acquisition of Nortis. Nortis' high-quality microphysiology systems (MPS) database and ability to accurately mimic human biology provided a unique value proposition, perfectly aligning with Quris-AI's mission to improve drug safety prediction. Nortis’s Kidney-on-Chip models, which set new standards for in-vitro drug testing and personalized medicine, will be combined with Quris-AI’s advanced machine learning models and patented patient-on-chip system that can predict a real human body’s reaction to drugs and eliminate potentially harmful drug candidates earlier in the drug development process.

Takara Bio Europe Expands Existing Gothenburg Site to Offer Custom Enzyme Manufacturing

Takara Bio Europe has announced the expansion of its Gothenburg facility, with the addition of a custom manufacturing lab. This new facility now offers a comprehensive array of customised molecular biology products, including PCR and qPCR enzymes, servicing the molecular biology needs of academic researchers, diagnostic labs, and biotech companies across EMEA, producing up to 600,000 reactions per week. With these expanded capabilities, customers can expect faster deliveries, personalised service, and real-time access to technical expertise, ensuring projects move forward efficiently while supporting sustainability goals through reduced carbon emissions.

Coronado Research Limited announce appointment of Professor Jennifer Visser-Rogers as Chief Scientific Officer

Coronado Research announced today that Professor Jennifer Visser-Rogers has been appointed as Chief Scientific Officer.

CluePoints Appoints Richard Young as Chief Strategy Officer

RBQM innovator CluePoints has today announced that Richard Young has been appointed as its new Chief Strategy Officer. With 30 years of experience in clinical data management, Richard is an expert in his field.

Sapio Sciences Adds Electronic Batch Record Functionality to Unified GMP LIMS Solution

Sapio Sciences today announced the addition of new Electronic Batch Record (EBR) functionality to Sapio GMP (Good Manufacturing Practice) LIMS. Designed for laboratories that must comply with GMP, 21 CFR 11, and EU Annex 11 standards, the Sapio GMP LIMS offers unparalleled flexibility to meet compliance standards in biotechnology, pharmaceuticals, clinical research and diagnostics, food and beverage, chemicals, and environmental testing.